Most follicular lymphoma cases exhibit classic clinicopathologic ... particularly in Waldeyer’s ring; t(14;18)-negative Grade 1/2 FLs; and nodal marginal zone lymphoma (NMZL).

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

The new use is the third for Kymriah (tisagenlecleucel) in the EU and offers patients with grade 1, 2 and 3A follicular lymphoma that has returned after two or more prior treatments a new ...

Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers—follicular lymphoma and marginal zone ...

Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.

This two-arm prospective phase III open-label trial randomly assigns (1:1) participants with low–tumor burden FL who wish to ... FL with blastoid or large centrocyte cytologic features, or follicular ...

New data from the Primary Rituximab And Maintenance study provide the strongest support for the use of rituximab maintenance in patients with follicular lymphoma ... %), notably grade 2–4 ...

CR 85% Previously transformed follicular lymphoma: ORR 100%; CR 73% ≥1 GELF criteria: ORR 97%; CR 75% High-risk FLIPI score: ORR 96%; CR 67% Response was durable: Among the responders ...